Archived This bill is from the 118th Congress (2023–2024) and is no longer under active consideration.
Bills/S.Res. 510118th Congress

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Senate: Referred
Cosponsors
35
Introduced
2023-12-14
Last action
2023-12-14

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. SenateLatest

    Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)

  2. Senate

    Introduced in Senate

Sign in to view Hilltelligence’s passage-probability analysis.

Topics

Policy area

Sign in to view Hilltelligence’s potential-cosponsor analysis.